BioNexus Gene Lab Corp. Financing Cash Flow
BioNexus Gene Lab Corp. (BGLC) reported Financing Cash Flow of $73.32 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- BioNexus Gene Lab Corp. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $13.61K.
- BioNexus Gene Lab Corp. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $59.71K.
- BioNexus Gene Lab Corp. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $266.54K.
- BioNexus Gene Lab Corp. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $34.19K.
- BioNexus Gene Lab Corp. net cash provided by (used in) financing activities for fiscal 2025 was $298.84K, a 7418.01% increase from fiscal 2024.
- BioNexus Gene Lab Corp. net cash provided by (used in) financing activities for fiscal 2024 was $3.98K, a 99.94% decline from fiscal 2023.
- BioNexus Gene Lab Corp. net cash provided by (used in) financing activities for fiscal 2023 was $6.27M, a 5701.10% increase from fiscal 2022.
- BioNexus Gene Lab Corp. net cash provided by (used in) financing activities for fiscal 2022 was $108.17K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $13.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $73.32K 10-Q · filed 2026-08-14 | $339.86K derived: sum of 3 quarters · filed 2026-08-14 | $374.05K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $59.71K 10-Q · filed 2026-05-15 | $326.25K derived: sum of 2 quarters · filed 2026-05-15 | $360.44K derived: sum of 3 quarters · filed 2026-05-15 | $359.41K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $266.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $300.73K derived: sum of 2 quarters · filed 2026-04-14 | $299.70K derived: sum of 3 quarters · filed 2026-08-14 | $298.84K 10-K · filed 2026-04-14 | ||||
| 2025-09-30 | $34.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $33.16K derived: sum of 2 quarters · filed 2026-08-14 | $32.30K 10-Q · filed 2025-11-14 | -$110.09K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$1.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.89K 10-Q · filed 2026-08-14 | -$144.28K derived: sum of 3 quarters · filed 2026-08-14 | -$200.26K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$860.00 10-Q · filed 2026-05-15 | -$143.25K derived: sum of 2 quarters · filed 2026-05-15 | -$199.23K derived: sum of 3 quarters · filed 2026-05-15 | -$23.82K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$142.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$198.37K derived: sum of 2 quarters · filed 2026-04-14 | -$22.95K derived: sum of 3 quarters · filed 2026-04-14 | $3.98K 10-K · filed 2026-04-14 | $144.97K 10-K · filed 2025-04-15 | |||
| 2024-09-30 | -$55.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $119.43K derived: sum of 2 quarters · filed 2025-11-14 | $146.36K 10-Q · filed 2025-11-14 | -$1.61K 10-Q · filed 2024-11-15 | $678.10K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $175.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $202.34K 10-Q · filed 2025-08-18 | $197.80K 10-Q · filed 2024-08-14 | $734.08K derived: sum of 3 quarters · filed 2025-08-18 | $6.48M derived: sum of 4 quarters · filed 2025-08-18 | |||
| 2024-03-31 | $26.93K 10-Q · filed 2025-05-15 | $24.22K 10-Q · filed 2024-05-15 | $558.66K derived: sum of 2 quarters · filed 2025-05-15 | $6.31M derived: sum of 3 quarters · filed 2025-05-15 | $6.30M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $531.73K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $6.28M derived: sum of 2 quarters · filed 2025-04-15 | $6.28M derived: sum of 3 quarters · filed 2025-04-15 | $6.27M 10-K · filed 2025-04-15 | $5.75M 10-K · filed 2024-04-16 | |||
| 2023-09-30 | $5.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | $5.74M derived: sum of 2 quarters · filed 2024-11-15 | $5.74M 10-Q · filed 2024-11-15 | $5.74M derived: sum of 4 quarters · filed 2024-11-15 | ||||
| 2023-06-30 | -$2.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$4.21K 10-Q · filed 2024-08-14 | -$6.49K derived: sum of 3 quarters · filed 2024-08-14 | -$8.22K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$1.78K 10-Q · filed 2024-05-15 | -$4.05K derived: sum of 2 quarters · filed 2024-05-15 | -$5.79K derived: sum of 3 quarters · filed 2024-05-15 | $106.39K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$2.27K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | -$4.01K derived: sum of 2 quarters · filed 2024-04-16 | $108.17K derived: sum of 3 quarters · filed 2024-04-16 | $108.17K 10-K · filed 2024-04-16 | $115.96K 10-K · filed 2023-03-31 | |||
| 2022-09-30 | -$1.74K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | $110.44K derived: sum of 2 quarters · filed 2024-03-26 | $110.44K 10-Q/A · filed 2024-03-26 | $115.96K 10-Q · filed 2022-11-14 | $105.48K derived: sum of 4 quarters · filed 2024-03-26 | |||
| 2022-06-30 | $112.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $112.18K 10-Q · filed 2023-08-16 | $115.96K 10-Q · filed 2022-08-15 | $107.22K derived: sum of 3 quarters · filed 2023-08-16 | $101.14K derived: sum of 4 quarters · filed 2023-08-16 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | -$4.96K derived: sum of 2 quarters · filed 2023-03-31 | -$11.04K derived: sum of 3 quarters · filed 2023-03-31 | -$19.67K derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-12-31 | -$4.96K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$11.04K derived: sum of 2 quarters · filed 2023-03-31 | -$19.67K derived: sum of 3 quarters · filed 2023-03-31 | -$28.22K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$6.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$14.71K derived: sum of 2 quarters · filed 2022-11-14 | -$23.26K 10-Q · filed 2022-11-14 | -$21.01K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$8.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$17.18K 10-Q · filed 2022-08-15 | -$14.93K derived: sum of 3 quarters · filed 2022-08-15 | -$12.74K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$8.55K 10-Q · filed 2022-05-16 | -$6.29K derived: sum of 2 quarters · filed 2022-05-16 | -$4.11K derived: sum of 3 quarters · filed 2022-05-16 | -$7.10K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $2.26K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $4.44K derived: sum of 2 quarters · filed 2022-04-06 | $1.45K derived: sum of 3 quarters · filed 2022-04-06 | -$4.95K 10-K · filed 2022-04-06 | ||||
| 2020-09-30 | $2.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$804.00 derived: sum of 2 quarters · filed 2021-11-15 | -$7.20K 10-Q · filed 2021-11-15 | -$5.60K 10-Q · filed 2020-11-03 | -$80.67K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | -$2.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$9.39K 10-Q · filed 2021-08-12 | -$7.97K 10-Q · filed 2020-08-11 | -$82.86K derived: sum of 3 quarters · filed 2021-08-12 | -$181.49K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | -$6.40K 10-Q · filed 2021-05-18 | -$8.27K 10-Q · filed 2020-05-08 | -$79.87K derived: sum of 2 quarters · filed 2021-05-18 | -$178.50K derived: sum of 3 quarters · filed 2021-05-18 | -$183.60K derived: sum of 4 quarters · filed 2021-05-18 | |||
| 2019-12-31 | -$73.47K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | -$172.10K derived: sum of 2 quarters · filed 2021-03-30 | -$177.20K derived: sum of 3 quarters · filed 2021-03-30 | -$180.81K 10-K · filed 2021-03-30 | ||||
| 2019-09-30 | -$98.63K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | -$103.73K derived: sum of 2 quarters · filed 2020-11-09 | -$107.33K 10-Q/A · filed 2020-11-09 | -$535.19K derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$5.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$8.70K 10-Q · filed 2020-08-11 | -$436.56K derived: sum of 3 quarters · filed 2020-08-11 | -$503.91K derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | -$3.61K 10-Q · filed 2020-05-08 | -$431.46K derived: sum of 2 quarters · filed 2020-05-08 | -$498.81K derived: sum of 3 quarters · filed 2020-05-08 | -$377.35K derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | -$427.86K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | -$495.21K derived: sum of 2 quarters · filed 2020-03-31 | -$373.74K derived: sum of 3 quarters · filed 2020-03-31 | $742.94K 10-K · filed 2020-03-31 | ||||
| 2018-09-30 | -$67.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $54.12K derived: sum of 2 quarters · filed 2019-11-14 | $1.17M 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | $121.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.24M 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | $1.12M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |